Amicus Therapeutics, Inc. (LON:0HF9)
London · Delayed Price · Currency is GBP · Price in USD 6.30
+0.21 (3.36%)
At close: Aug 1, 2025
Amicus Therapeutics Market Cap
Amicus Therapeutics has a market cap or net worth of 1.47 billion as of August 1, 2025. Its market cap has decreased by -39.08% in one year.
Market Cap
1.47B
Enterprise Value
1.63B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.30
Market Cap Chart
Since May 31, 2007, Amicus Therapeutics's market cap has increased from 162.11M to 1.47B, an increase of 807.23%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.47B | -34.59% |
| Dec 31, 2024 | 2.25B | -31.18% |
| Dec 29, 2023 | 3.27B | 14.75% |
| Dec 30, 2022 | 2.85B | 19.78% |
| Dec 31, 2021 | 2.38B | -46.07% |
| Dec 31, 2020 | 4.41B | 135.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 178.30B |
| GSK plc | 59.04B |
| Haleon | 32.79B |
| Smith & Nephew | 10.24B |
| ConvaTec Group | 4.72B |
| Hikma Pharmaceuticals | 4.40B |
| HUTCHMED (China) | 2.34B |
| Oxford Nanopore Technologies | 1.94B |